Vision care is gaining strategic importance in Saudi Arabia as public policy, private investment, and clinical adoption of advanced diagnostics converge. Grand View Research projects the Saudi Arabia eye care market to reach USD 809.2 million by 2030, with a forecast CAGR of 3.5% from 2024 to 2030. In the product mix, contact lenses were the largest revenue-generating product in 2023, and in 2024 they held a 36.66% revenue share. The same outlook also points to ocular health products as the most lucrative segment, registering the fastest growth during the forecast period, reflecting demand beyond basic correction.
A second set of forecasts frames the medium-term trajectory. Renub Research figures, republished by Vocal Media, expect the Saudi Arabia vision care market to reach US$ 1,292.62 million by 2033, up from US$ 899.58 million in 2024, at a CAGR of 4.11% from 2025 to 2033. The same source attributes growth to demographic shifts, technological progress, higher health awareness, and expanding healthcare infrastructure. It also emphasizes that Vision 2030 reforms are improving access to specialized medical services, including ophthalmology, across public and private facilities, with investments directed toward building and upgrading hospitals, clinics, and specialized medical centers.
Growth Drivers Reshaping Demand Across Devices, Services, and Sites of Care
Device demand adds another lens into how Saudi Arabia’s vision ecosystem is developing. Mordor Intelligence estimates the Saudi Arabia ophthalmic devices market will grow from USD 580 million in 2025 to USD 611.21 million in 2026, reaching USD 794.18 million by 2031 at a 5.38% CAGR over 2026–2031. It links this advance to Vision 2030’s USD 65 billion healthcare-modernization plan. In this market, vision care devices held 59.83% share in 2025, while diagnostic and monitoring devices are projected to expand at a 7.42% CAGR through 2031—consistent with a stronger push toward earlier detection and technology-led workflows.
Clinical need is also shaping purchasing priorities. Mordor Intelligence notes sustained demand arising from a diabetes burden that climbed to 7 million cases in 2021 and is expected to hit 8.4 million by 2030, increasing the need for screening and monitoring technologies. It also states that diabetes affects 31.0% of adults in the Kingdom, and that diabetic retinopathy impacts 46% of diabetics in the Western region. In disease mix, cataract accounted for 35.12% of the ophthalmic devices market in 2025, while diabetic retinopathy is set to grow at a 6.74% CAGR to 2031. These figures help explain why AI diagnostics and tele-ophthalmology are being adopted to improve throughput.
Where care is delivered is evolving alongside technology and investment, creating new operational models within the Saudi ophthalmology market. Mordor Intelligence reports hospitals commanded a 45.05% revenue share in 2025, while ambulatory surgery centers are expected to post a 6.55% CAGR during 2026–2031. It adds that Riyadh and Jeddah are emerging as medical-tourism hubs and that rapid adoption of AI diagnostics and growing private investment in ambulatory eye-care centers are energizing the market. At the system level, it states Vision 2030 seeks to raise private-sector participation in healthcare to 68% by 2030, and notes SEHA Virtual Hospital links more than 150 hospitals to extend specialist reach through remote assessments.
What is the projected outlook for Saudi Arabia’s eye care market by 2030?
Which product segment leads revenue share in Saudi Arabia’s eye care market?
How fast is Saudi Arabia’s ophthalmic devices market expected to grow?
How is diabetes influencing demand in Saudi Arabia’s ophthalmology sector?
What are key growth drivers in the Saudi ophthalmology market under Vision 2030?
